Growth Metrics

Glucotrack (GCTK) EPS (Basic) (2016 - 2020)

Glucotrack's EPS (Basic) history spans 7 years, with the latest figure at $0.1 for Q4 2020.

  • For the quarter ending Q4 2020, EPS (Basic) rose 1100.0% year-over-year to $0.1, compared with a TTM value of $0.03 through Dec 2020, up 175.0%, and an annual FY2025 reading of $31.22, down 99.24% over the prior year.
  • EPS (Basic) for Q4 2020 was $0.1 at Glucotrack, up from -$0.03 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.48 in Q1 2017, with the low at -$3.78 in Q4 2018.
  • Average EPS (Basic) over 5 years is -$0.3, with a median of -$0.14 recorded in 2016.
  • Year-over-year, EPS (Basic) tumbled 704.26% in 2018 and then surged 1100.0% in 2020.
  • Tracing GCTK's EPS (Basic) over 5 years: stood at -$0.24 in 2016, then plummeted by 95.83% to -$0.47 in 2017, then tumbled by 704.26% to -$3.78 in 2018, then surged by 99.74% to -$0.01 in 2019, then soared by 1100.0% to $0.1 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's EPS (Basic) are $0.1 (Q4 2020), -$0.03 (Q3 2020), and -$0.04 (Q2 2020).